Respiratory Medicine Case Reports (Jan 2022)

Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report

  • Yasutaka Mochizuka,
  • Tomoyuki Fujisawa,
  • Yusuke Inoue,
  • Hironao Hozumi,
  • Yuzo Suzuki,
  • Masato Karayama,
  • Kazuki Furuhashi,
  • Noriyuki Enomoto,
  • Yutaro Nakamura,
  • Naoki Inui,
  • Takafumi Suda

Journal volume & issue
Vol. 37
p. 101632

Abstract

Read online

We report herein a case of trimethoprim-sulfamethoxazole (TMP-SMX) induced eosinophilic pneumonia in a 27-year-old woman with radiological features of bilateral nonsegmental airspace consolidation resembling cryptogenic organizing pneumonia at the peripheral lung fields. Organizing pneumonia with eosinophil infiltration in the lung specimens and marked eosinophilia in the peripheral blood and bronchoalveolar lavage fluid were observed. Discontinuation of TMP-SMX improved eosinophilia and radiological abnormality, which confirmed the association between the use of TMP-SMX and onset of eosinophilic pneumonia. Although TMP-SMX induced eosinophilic pneumonia is not common, clinician should be aware that drug-induced eosinophilic pneumonia could happen during the course of TMP-SMX administration.

Keywords